Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The Alliance for Lupus Research (ALR) is an independent, voluntary health agency formed to provide a concentrated effort for the prevention, treatment and cure of systemic lupus erythematosus (lupus or SLE). The purpose of the ALR Target Identification in Lupus (TIL) grants program is to fund highly meritorious and innovative research focused on the identification and scientific and/or clinical advancement of therapeutic targets that will lead to new therapies for the treatment of lupus. This grant program has been established to develop new approaches to treat lupus more effectively and safely. |
Característiques principals
The goals of the TIL grant program are to: (1) characterize key steps in the pathogenesis of the disease that will allow for the development of new therapeutic agents; (2) promote basic and clinical research studies to identify and/or better characterize promising lead compounds for lupus treatment; (3) support research that facilitates the clinical evaluation of innovative approaches to the prevention or treatment of lupus and its complications. |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
Convocatòria (URL)
Call: http://www.lupusresearch.org/lupus-research/for-researchers.html#.Vk8PNXbRYgt |
Informació addicional
Proposals should be submitted through the Altum proposal CENTRAL website: https://proposalcentral.altum.com Instructions and application forms should be downloaded from the proposal CENTRAL. |
Requisits
Individuals with doctoral degrees (MD, PhD, DO or equivalent) are eligible to apply. Scientific independence, as evidenced by direction of a research program, a publication record, or other experience that establishes scientific leadership is necessary to apply. The ALR does not impose geographic restrictions on its applicants. Investigators working anywhere in the world are eligible to apply. The ALR is willing to appropriately support research in industry or collaborations between academia and industry. Only one application will be accepted per principal investigator in a grant cycle. |
Dotació
Up to $200,000 per year (for a maximum of three years - total amount up to $600,000) including indirect costs. |
Durada
Maximum 3 years. |
Documentació
A non-binding letter of intent must be submitted by the investigator in advance of an invitation to apply for a grant. The letter must include a summary of the general theme and the potential future clinical ramification of the project future should it be successful. |
AVÍS IMPORTANT
LOIs should be submitted electronically through proposal CENTRAL no later than December 23rd, 2016, 5 p.m. (EST) Full Application should be submitted by February 17th, 2017. |
Arxius
Arxiu |
---|
Guidelines |